Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: €4.31 M
• Last 3 months FTD volume: €26.28 M
• Last year FTD volume: €26.28 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€56.79 M	€0.30 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€6.54 M	€27.3 M	🇺🇸 USA
AbbVie ABBV	€72.85 M	€0.15 B	🇺🇸 USA
Illumina ILMN	€39.39 M	€69.85 M	🇺🇸 USA
Biogen BIIB	€8.32 M	€67.37 M	🇺🇸 USA
Pfizer PFE	€0.18 B	€0.53 B	🇺🇸 USA
Johnson & Johnson JNJ	€70.4 M	€0.32 B	🇺🇸 USA
Eli Lilly LLY	€42.55 M	€0.15 B	🇺🇸 USA
Merck MRK	€21.36 M	€84.84 M	🇺🇸 USA